Israel’s Nutrina Raises $12 Million for Pre-Term Infant Insulin Treatment

Israeli company Nutrinia, which develops oral insulin therapies to treat rare gastrointestinal disorders, has raised $12 million. The company said that funds from the round will be used to advance two multinational More...